Elicio Therapeutics (ELTX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Elicio Therapeutics (ELTX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Elicio Therapeutics

· ELTX

Dashboard

Financials

Ratios

Valuation

Statistics

48.359 M

-1.09%

General

Market Cap: $48.36M
Enterprise Value: $25.37M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -120.78%
ROE: -1266.43%
ROIC: -163.43%
Current Ratio: 2.77
Debt-to-Equity: 1.78
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 4.37
EV/EBITDA: -0.63

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $37.63M
Operating Income: -$37.92M
Net Profit: -$37.84M

Balance Sheet

Cash and Equivalents: $23.48M
Working Capital: $16.28M
Total Assets: $31.33M
Net Debt: -$9.33M
Total Liabilities: $23.39M
Total Equity: $7.94M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$37.69M
Cash Flow from Investing: -$16K
Cash Flow from Financing: $38.97M
Free Cash Flow: -$37.71M
Capital Expenditures: $16K